Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios leon farma, s.a. - etonogestrel; ethinylestradiol ph.eur. - vaginal delivery system - 0.120/0.015 milligram(s) - intravaginal contraceptives; vaginal ring with progestogen and estrogen

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ethinylestradiol 2.7mg (15µg/24h elution rate in-vivo);  ; etonogestrel 11.7mg (120µg/24h elution rate in-vivo);   - vaginal ring - 120mcg etonogestrel, 15mcg ethinylestradiol / 24h - active: ethinylestradiol 2.7mg (15µg/24h elution rate in-vivo)   etonogestrel 11.7mg (120µg/24h elution rate in-vivo)   excipient: evatane 1020 vn3 ethylene/vinyl acetate co-polymer evatane 28-25 ethylene/vinyl acetate co-polymer magnesium stearate - contraception.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - levonorgestrel, quantity: 100 microgram; ethinylestradiol, quantity: 20 microgram - tablet, film coated - excipient ingredients: povidone; lactose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - oral contraception.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levonorgestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - oral contraception

Israel - English - Ministry of Health

dexcel ltd, israel - ethinylestradiol; gestodene - tablets - ethinylestradiol 0.02 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - contraceptive.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; magnesium stearate; lactose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - indicated for use as an oral contraceptive

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; glycol montanate; sucrose; povidone; titanium dioxide; iron oxide yellow; calcium carbonate; glycerol; purified talc; macrogol 6000 - indicated for the prevention of pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; titanium dioxide; magnesium stearate; maize starch; hypromellose; polysorbate 80; triacetin; indigo carmine aluminium lake; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate - oral contraception

Israel - English - Ministry of Health

bayer israel ltd - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - hormonal contraception.